TY  - GEN
AU  - Moasser,Mark M
AU  - Krop,Ian E
TI  - The Evolving Landscape of HER2 Targeting in Breast Cancer
SN  - 2374-2445
PY  - 2016///0329
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - antagonists & inhibitors
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Genetic Testing
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Phenotype
KW  - Precision Medicine
KW  - Protein Kinase Inhibitors
KW  - Receptor, ErbB-2
KW  - Signal Transduction
KW  - drug effects
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
UR  - https://doi.org/10.1001/jamaoncol.2015.2286
ER  -